Bio Key International (BKYI) EBIT (2016 - 2025)
Historic EBIT for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to -$892190.0.
- Bio Key International's EBIT fell 5371.85% to -$892190.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year increase of 2895.35%. This contributed to the annual value of -$4.0 million for FY2024, which is 5455.59% up from last year.
- Latest data reveals that Bio Key International reported EBIT of -$892190.0 as of Q3 2025, which was down 5371.85% from -$1.1 million recorded in Q2 2025.
- In the past 5 years, Bio Key International's EBIT ranged from a high of -$508934.0 in Q1 2024 and a low of -$5.0 million during Q4 2022
- For the 5-year period, Bio Key International's EBIT averaged around -$1.6 million, with its median value being -$1.3 million (2024).
- As far as peak fluctuations go, Bio Key International's EBIT plummeted by 45377.66% in 2021, and later soared by 7105.7% in 2024.
- Bio Key International's EBIT (Quarter) stood at -$2.0 million in 2021, then crashed by 149.89% to -$5.0 million in 2022, then soared by 45.48% to -$2.7 million in 2023, then surged by 53.46% to -$1.3 million in 2024, then increased by 29.62% to -$892190.0 in 2025.
- Its EBIT was -$892190.0 in Q3 2025, compared to -$1.1 million in Q2 2025 and -$640638.0 in Q1 2025.